590 - Impact of Universal Nasal Decolonization with an Alcohol-Based Nasal Antiseptic (ABNA) Versus Mupirocin on Infection Rates and Antimicrobial Utilization in Patients (Pts) Admitted to the Burn Service

Co-Author(s)

• AB

  Arefa Bacchus, PharmD

  Atrium Health Wake Forest Baptist
  Winston-Salem, North Carolina, United States

Co-Author(s)

• 

  Werner Bischoff, MD PhD (he/him/his)

  Med Director Infection Prevention
  Wake Forest University School of Medicine
  Winston Salem, NC, United States
• MB

  Mary Banoub, PharmD, BCIDP, CPP

  Atrium Health Wake Forest Baptist Medical Center
  Winston Salem, North Carolina, United States
• 

  Olivia Randazza, PharmD

  Infectious Diseases Pharmacy Practice Lead
  Atrium Health Wake Forest Baptist
  Winston-Salem, North Carolina, United States
• 

  Vera P. Luther, MD (she/her/hers)

  Professor of Medicine
  Wake Forest University School of Medicine
  Winston Salem, NC, United States
• 

  James R. Beardsley, PharmD

  Assistant Professor
  Wake Forest University School of Medicine
  Winston Salem, North Carolina, United States
• 

  John C. Williamson, PharmD

  Program Administrator, Infectious Diseases Research
  Atrium Health Wake Forest Baptist
  Winston-Salem, NC, United States
• KR

  Kristin Rebo, PharmD, BCCCP

  Critical Care Clinical Pharmacist
  Atrium Health Wake Forest Health
  Winston Salem, North Carolina, United States
• SG

  Seth Garner, PharmD, BCCCP

  Trauma ICU Pharmacist
  Atrium Health Wake Forest Medical Center
  Winston Salem, North Carolina, United States
• 

  Michael E. DeWitt, MS

  Research Data Scientist
  Atrium Wake Forest Baptist Health/ Wake Forest University School of Medicine
  Winston-Salem, North Carolina, United States

Presenting Author(s)

• 

  Alex D. Taylor, PharmD (she/her/hers)

  Infectious Diseases Pharmacy Practice Lead
  Atrium Health Wake Forest Baptist
  Kernersville, North Carolina, United States

  Slides